OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Improving these processes involves adjusting various variables, including cell line development, media formulation, and bioreactor environments. A key goal is to maximize antibody titer while lowering production costs